ClassID:

96221

C07F9/655354 - CPC Classification

Classification description:

Compounds containing elements of Groups 5 or 15 of the Periodic System; Phosphorus compounds; Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a five-membered ring condensed with carbocyclic rings or carbocyclic ring systems

Recent Application in this class:
#1
20260132157
2026-05-14

HYDROXYAMINOPHOSPHINIC ACID DERIVATIVES

#2
20260092078
2026-04-02

STAT6 DEGRADERS AND USES THEREOF

#3
20250304608
2025-10-02

PHOSPHORUS COMPOUND AND USE THEREOF

#4
20250289837
2025-09-18

MITOCHONDRIOTROPIC HETEROARYL BENZAMIDE POTASSIUM CHANNEL KV1.3 INHIBITORS

#5
20250059220
2025-02-20

SUBSTITUTED BENZOTHIOPHENE DERIVATIVES AND METHODS OF USE THEREOF

#6
20230159573
2023-05-25

SMALL MOLECULE STAT PROTEIN DEGRADERS

#7
20220278296
2022-09-01

LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS INCLUDING THE SAME

#8
20210171554
2021-06-10

BENZOTHIOPHENE ESTROGEN RECEPTOR MODULATORS TO TREAT MEDICAL DISORDERS

#9
20210155645
2021-05-27

Enhancing CD8+ T cells for adoptive T cell therapy by inhibiting PTPN1 (PTP1B) and PTPN2 (TC-PTP)

#10
20200339525
2020-10-29

Methods and compositions for inhibition of STAT3

#11
20190322623
2019-10-24

COMPOUND, DISPLAY PANEL, AND DISPLAY APPARATUS

#12
20190218193
2019-07-18

Substituted tricyclic heterocyclic compounds

#13
20180319829
2018-11-08

Phosphinic peptide derivatives for use as MMP-12 inhibitors

#14
20180265531
2018-09-20

TC-PTP inhibitors as APC activators for immunotherapy

#15
20180248126
2018-08-30

Heterocyclic compound and organic light emitting diode comprising same

#16
20180072763
2018-03-15

TC-PTP inhibitors as APC activators for immunotherapy

#17
20170015690
2017-01-19

TC-PTP inhibitors as APC activators for immunotherapy

#18
20170012209
2017-01-12

Compound, material for organic electroluminescent elements, organic electroluminescent element and electronic device

#19
20160343950
2016-11-24

Compound, material for organic electroluminescent elements, organic electroluminescent element and electronic device

#20
20160064676
2016-03-03

Compound having diazatriphenylene ring structure, and organic electroluminescent device

#21
20160020402
2016-01-21

Compound, light emitting material, and organic light emitting device

#22
20150025039
2015-01-22

Antiviral phosphonate analogs

#23
20140135530
2014-05-15

Compound and organic device employing same

#24
20140100194
2014-04-10

Cold menthol receptor-1 antagonists

#25
20120309986
2012-12-06

Process for the preparation of chymase modulators

#26
20120259130
2012-10-11

PROCESS FOR SYNTHESIZING PHOSPHONIC AND PHOSPHINIC ACID COMPOUNDS

#27
20120211082
2012-08-23

PHOTOELECTRIC CONVERSION DEVICE AND SOLAR CELL USING THE SAME

#28
20120184510
2012-07-19

Cold menthol receptor-1 antagonists

#29
20120053347
2012-03-01

Cold menthol receptor-1 antagonists

#30
20120012821
2012-01-19

Silyl- and heteroatom-substituted compounds selected from carbazoles, dibenzofurans, dibenzothiophenes and dibenzophospholes, and use thereof in organic electronics

#31
20110288053
2011-11-24

ANTIVIRAL PHOSPHONATE ANALOGS

#32
20110272684
2011-11-10

Materials for organic electroluminescence devices

#33
20110118482
2011-05-19

Bidentate chiral ligands for use in catalytic asymmetric addition reactions

#34
20110098485
2011-04-28

Bidentate secondary phosphine oxide chiral ligands for use in asymmetric addition reactions

#35
20100317625
2010-12-16

NOVEL SULFONAMIDOMETHYLPHOSPHONATE INHIBITORS OF BETA-LACTAMASE

#36
20100279983
2010-11-04

Inhibitors of beta-lactamase

#37
20100210595
2010-08-19

Substituted arylsulfonylaminomethylphosphonic acid derivatives, their preparation and their use in the treatment of type I and II diabetes mellitus

#38
20100210594
2010-08-19

Substituted arylsulfonylaminomethylphosphonic acid derivatives, their preparation and their use in the treatment of type I and II diabetes mellitus

#39
20100179216
2010-07-15

Amine compound and pharmaceutical use thereof

#40
20100145075
2010-06-10

Process for the preparation of chymase modulators

#41
20090275535
2009-11-05

Antiviral phosphonate analogs

#42
20090169475
2009-07-02

RADIOLABELED DERIVATIVES OF POTENT CHYMASE INHIBITORS

#43
20090124801
2009-05-14

Process for synthesizing phosphonic and phosphinic acid compounds

#44
20090036409
2009-02-05

Novel inhibitors of chymase

#45
20080306264
2008-12-11

Cycloolefin phosphine ligands and their use in catalysis

#46
20080287398
2008-11-20

COLD MENTHOL RECEPTOR-1 ANTAGONISTS

#47
20080194524
2008-08-14

Compounds For the Inhibition of Undesired Cell Proliferation and Use Thereof

#48
20080125609
2008-05-29

Compounds for Organic Electronic Devices

#49
20080119441
2008-05-22

Phosphonic acid derivatives and the treating agents of diseases related hyperphosphatemia

#50
20080027029
2008-01-31

Cold menthol receptor-1 antagonists

#51
20070293675
2007-12-20

Inhibitors of β-lactamase

#52
20070241670
2007-10-18

Organic materials with phosphine sulfide moieties having tunable electric and electroluminescent properties

#53
20060247215
2006-11-02

Cyclohexyl prostaglandin analogs as EP-receptor agonists

#54
20060241307
2006-10-26

Ligands for asymmetric reactions

#55
20060142252
2006-06-29

Tubulin binding agents and corresponding prodrug constructs

#56
20060105999
2006-05-18

Novel inhibitors of beta-lactamase

#57
20060030606
2006-02-09

Cyclohexyl prostaglandin analogs as EP-receptor agonists

#58
20050256078
2005-11-17

Inosine monophosphate dehydrogenase inhibitory phosphonate compounds

#59
20050250742
2005-11-10

Phosphate/sulfate ester compounds and pharmaceutical composition for inhibiting protein interacting NIMA (PIN1)

#60
20050215513
2005-09-29

Antiviral phosphonate analogs

#61
20050176769
2005-08-11

Inhibitors of chymase

#62
20050124588
2005-06-09

Method of treating a condition by administering a prostaglandin derivative

#63
20050124587
2005-06-09

2-decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use

#64
20050049227
2005-03-03

Cyclohexyl prostaglandin analogs as EP-receptor agonists

#65
20050043276
2005-02-24

Inhibitors of β-lactamase